ErVimmune
ErVimmune creates novel immunotherapies that target non-conventional tumor antigens that are abnormally expressed in cancer cells and shared by tumors and patients, with a particular emphasis on meeting unmet medical requirements in cold malignancies.
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does ErVimmune use?+
ErVimmune uses 15 technologies including jQuery Migrate, SVG Support, MySQL.
What industry is ErVimmune in?+
ErVimmune operates in the Biopharma industry.
Where is ErVimmune based?+
ErVimmune is headquartered in France.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026